Oncotarget

Corrections:

Correction: Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/β-catenin signaling

PDF  |  How to cite

Oncotarget. 2021; 12:2434-2434. https://doi.org/10.18632/oncotarget.28142

Metrics: PDF 26 views  |   ?  

Kun Zhang1,*, Minhui Li2,*, Houyi Huang1,*, Linpeng Li1,*, Jie Yang1, Li Feng1, Junjie Gou1, Mengju Jiang1, Liaotian Peng1, Linyi Chen1, Ting Li1, Ping Yang2, Yuhan Yang1, Yuanyuan Wang1, Quekun Peng1, Xiaozhen Dai1 and Tao Zhang1

1School of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China
2School of Basic Medical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China
*These authors contributed equally to this work

Published: November 23, 2021

Copyright: © 2021 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: In Figure 2E, the MRP2 blot panel was inadvertently duplicated in the BCRP blot panel. The corrected Figure 2E, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:115803–115816. DOI: https://doi.org/10.18632/oncotarget.23253

Figure 2: DVL increased expressions of P-gp, MRP2 and BCRP. (E) HCT-8/VCR cells transfected with shNC, shDVL, or shDVL plus pcDNA3.1-Flag-DVL for 72 h, were lysed to examine the protein levels of P-gp, MRP2 and BCRP, Flag-DVL1-3 and DVL1-3 using Western blotting. In each case, the blot was representative of immunoblots resulting from three separate experiments.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 28142